Описание пользователя

BENGALURU, May 26 (Reuters) - Glenmark Pharmaceuticals Ltd said on Tuesday it will begin a new clinical trial in India to test a combination of two anti-viral drugs - favipiravir and umifenovir - as a potential COVID-19 treatment.


If you treasured this article so you would like to collect more info regarding https://75b.tv/home.php?mod=space&uid=8894&do=profile&from=space kindly visit our web-page.